Wire · regulatory
FDA Clears AI-Powered Breast Ultrasound Software from DeepHealth
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 31 July 2026 · Fusion42 review
The U.S. Food and Drug Administration (FDA) has granted clearance to DeepHealth's AI-powered breast ultrasound software. The tool, which automates lesion detection and characterization, reportedly demonstrates over 98% sensitivity in localizing lesions and reduces radiologist interpretation time by 37%.
This Wire brief sits within Fusion42's coverage of Diagnostics, and 3 sources have reported it between 31 Jul 2026 and 4 Aug 2026.
◆ ◆ The Wire takeaway
The FDA just set the performance bar for AI in breast cancer diagnostics. If your tool doesn't beat 98% sensitivity and a 37% reduction in radiologist time, you are now behind the standard for both regulators and customers.
◆ Coverage
3 sources · first reported 31 Jul 2026 · latest 4 Aug 2026
◆ Related on Wire
◆ Topics